Singapore markets close in 3 hours 52 minutes

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
1.02000.0000 (0.00%)
As of 05:04PM SGT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
6,969,974
6,907,544
6,603,652
6,993,882
6,358,622
Cost of revenue
4,238,314
4,150,424
4,027,755
4,046,928
3,722,834
Gross profit
2,731,659
2,757,120
2,575,897
2,946,953
2,635,789
Operating expenses
Research development
151,410
161,052
149,202
133,361
100,925
Selling general and administrative
1,633,984
1,645,040
1,541,679
1,914,801
1,760,449
Total operating expenses
2,124,610
2,143,941
1,979,962
2,380,869
2,159,627
Operating income or loss
607,050
613,179
595,934
566,084
476,162
Interest expense
-
2,937
6.66
4,893
11,382
Income before tax
857,141
872,806
768,058
743,145
640,629
Income tax expense
84,834
85,929
88,396
107,786
72,841
Income from continuing operations
772,307
786,877
679,662
635,359
567,788
Net income
755,800
769,144
661,704
625,569
561,680
Net income available to common shareholders
755,800
769,144
661,704
625,569
561,680
Basic EPS
-
1.00
0.86
0.81
0.73
Diluted EPS
-
1.00
0.86
0.81
0.73
Basic average shares
-
769,144
769,424
772,307
769,424
Diluted average shares
-
769,144
769,424
772,307
769,424
EBITDA
-
991,277
878,913
846,187
728,159